Stock·NASDAQ·Consumer Cyclical
Starbucks Corp. (SBUX)
- Market cap
- $111.17B
- P/E
- 55.36
- Dividend yield
- 2.55%
- Street target
- $111.00median of 35 analysts
- 52-week range
- $77.99 $110.51
The short version
Where SBUX stands today, in four lines, and what CleaRank Financial AI makes of it.
SBUX at a glance
Starbucks Corp. (SBUX): Hold, 41/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($100.21 and $99.16).
- Earnings SBUX beat estimates in 3 of its last 7 quarters, and the stock rose the next day every time.
- Insiders Insiders sold $2.2M and bought $995K over the last 18 months.
- Valuation P/E of 55.4 against 20.8 for the Consumer Cyclical sector: a premium to peers (+166%).
Figures as of October 16, 2026.
CleaRank Financial AI
Starbucks Corp. (SBUX) carries a CleaRank rating of Hold and a model score of 41/100.
The analysts' outlook is the biggest support, with the median target 13.8% above the price. Valuation is the biggest drag: the P/E of 55.36 sits 166.2% above the sector median (a premium to peers), and the P/S of 2.88 sits 51.6% above the sector median. The trend points down, with SBUX 2.68% below its 50-day average of $100.21 and 1.65% below its 200-day average of $99.16. The price still rose 15.63% over the past year.
Only on CleaRank
Figures we compute ourselves from SBUX's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
2/4Price above its 50-day average ›
The price of $97.52 is 2.7% below the 50-day simple moving average of $100.21.Price above its 200-day average ›
The price is 1.7% below the 200-day simple moving average of $99.16.50-day average above the 200-day ›
The 50-day average ($100.21) is 1.1% above the 200-day average ($99.16), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 60% of its 52-week range, between $77.99 and $110.51.
SBUX share price
Pick a period: each tab shows how far SBUX has moved over it, to the last close.
Today's trading
Where SBUX sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
2/5P/E below the sector median ›
The trailing P/E of 55.36 is 166.2% above the Consumer Cyclical median of 20.8.P/S below the sector median ›
The price-to-sales ratio of 2.88 is 51.6% above the sector median of 1.9.Profitable over the last 12 months ›
Net income over the last 12 months was $2.0B on revenue of $38.3B, a net margin of 5.2%.Beat estimates in most recent reports ›
SBUX beat the EPS estimate in 3 of its last 7 reports.Pays a dividend ›
The trailing dividend yield is 2.55%, or $2.49 a share a year.
Key statistics
The headline figures for SBUX.
As of October 16, 2026, SBUX trades at $97.52, with a market value of $111.17B, a P/E ratio of 55.36 and a dividend yield of 2.55%.
What the numbers say
CleaRank Financial AI's reading of SBUX's valuation, growth and risks.
SBUX carries a trailing P/E of 55.36, which is 166.2% above the Consumer Cyclical median of 20.8. The Peer Benchmarking card describes this as a premium to peers. Its price-to-sales ratio is 2.88, 51.6% above the sector median of 1.9. The market capitalisation of SBUX stands at $111.2B.
Growth trails the sector: revenue fell 1.40% in the latest year, against a sector median of 7.2%. SBUX keeps a net margin of 5.17% and an operating margin of 12.92%. It generates a return on equity of -22.95%, below the sector median of 12.4%. Rounding out the fundamentals, SBUX reports a trailing dividend yield of 2.55% ($2.49 a share a year).
SBUX's last earnings report, on July 29, 2026, beat the estimate by 30.77%, with EPS of $0.85 against an estimate of $0.65. The market agreed: the stock rose 1.64% the following session.
SBUX beat the EPS estimate in 3 of its last 7 reports, and every one of those beats was followed by a gain the next day. The largest of the earlier reactions came after the April 28, 2026 report, which beat the estimate by 13.64% while the stock rose 8.45%. Analysts' average EPS estimate for this fiscal year is $2.60, which would be growth of 22.1%, and $3.13 for next year (growth of 20.2%).
The P/E of 55.36, 166.2% above the sector median, puts SBUX at a premium to peers, so weaker results would meet a higher bar. Normal swings for SBUX run at about 1.46% a day. Until the price regains its moving averages, the trend works against holders. Insiders sold $2.2M over the last 18 months and bought $995K, though sales of this kind are often planned in advance and say less than purchases would.
SBUX against the Consumer Cyclical sector
How SBUX compares with the median Consumer Cyclical stock CleaRank tracks.
Price to earnings vs sector: SBUX trades at a significant premium to sector peers (+166%), suggesting market expectations for superior growth or market position.
Return vs SPY: Since May 6, 2025, SBUX has gained 17.8% against a gain of 36.6% for SPY.
Performance against SPY
SBUX and the Consumer Cyclical sector fund over the same days.
Revenue and earnings
How much SBUX sells, and how much of it becomes profit.
Revenue growth: Revenue grew 2.8% in FY2025 to $37.2B, from $36.2B a year earlier.
Profit margin: The net margin was 5.0% in FY2025, down from 10.4% the year before.
Profitable: SBUX earned $1.9B in FY2025.
Earnings reality check
Did SBUX beat what analysts expected, and how did the stock react?
Earnings record: SBUX beat the analyst estimate in 3 of the last 7 quarters.
Market reaction: The stock rose in the first session after every beat.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 29, 2026after close | $0.65 | $0.85 | +30.77% | +1.64% | +1.79% |
| Apr 28, 2026after close | $0.44 | $0.50 | +13.64% | +8.45% | +7.87% |
| Oct 29, 2025after close | $0.56 | $0.52 | -7.14% | -1.21% | -1.53% |
| Jul 29, 2025after close | $0.65 | $0.50 | -23.08% | -0.22% | -2.97% |
| Apr 29, 2025after close | $0.48 | $0.41 | -14.58% | -5.66% | -2.44% |
| Jan 28, 2025after close | $0.67 | $0.69 | +2.99% | +8.14% | +10.15% |
| Oct 30, 2024after close | $0.89 | $0.80 | -10.11% | +0.39% | -1.27% |
As of October 16, 2026, SBUX has beaten the analyst EPS estimate in 3 of its last 7 reported quarters and rose in the first trading session after every one of those beats; its latest report, on July 29, 2026, came in 30.77% above the estimate and the stock moved +1.64% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/3RSI not overbought or oversold ›
The 14-day RSI is 54.5, in neutral territory.RSI above 50 ›
An RSI of 54.5 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of SBUX
The score, the reasoning behind it, and what could move the price next.
Starbucks Corp. (SBUX) is trending down. The stock, at $97.52, sits 2.68% below its 50-day average of $100.21 and 1.65% below its 200-day average of $99.16. The 50-day average is still 1.05% above the 200-day, so the longer average has not yet adjusted to the weaker price. Over the past year, the price is 25.04% above the 52-week low of $77.99, yet 11.75% below the 52-week high of $110.51.
Short-term and long-term readings disagree. Over the past month the price rose 0.18%, yet over three months it fell 7.56%, while over the past year it rose 15.63%. In the last session the price rose 0.66% on volume that was 37.8% below its average. The 14-day RSI sits at 54.5, which is neutral, and the MACD line is negative.
Earnings beat ›
The July 29, 2026 report beat the EPS estimate by 30.77%, and the share price rose 1.64% in the first session after it.
Source: Earnings report, July 29, 2026Rating reaffirmed ›
DA Davidson kept its Neutral rating on October 9, 2026.
Source: Analyst action, DA Davidson, October 9, 2026
New analyst coverage ›
Seaport Global started coverage at Neutral on September 16, 2026.
Source: Analyst action, Seaport Global, September 16, 2026
- Keep an eye on the two closest levels: the 200-day SMA at $99.16 overhead and the 20-day EMA at $95.28 underneath.
- The 14-day RSI reads 54.5, in the neutral zone, with the MACD line negative; readings above 70 or below 30 mark stretched momentum.
- The share price rose 1.64% in the first session after the July 29, 2026 report. SBUX has beaten estimates in 3 of the last 7 reports.
SBUX is trading beneath both its 50-day ($100.21) and 200-day ($99.16) averages, and that is why the trend reads down. A move back above the 200-day would be the first sign of repair. That average, at $99.16, is the nearest level above the price.
The next marker below the price is the 20-day EMA, at $95.28.
Technical indicators
Momentum and trend for SBUX, from its daily closes.
As of October 16, 2026, with SBUX at $97.52, its 14-day RSI is 54.5 (neutral territory), its 50-day simple moving average is $100.21 and its 200-day is $99.16.
Calculated by CleaRank on daily closes as of October 16, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What SBUX moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 16, 2026, SBUX's 1-year correlation of daily returns is +0.44 with S&P 500 (SPY), +0.37 with Nasdaq 100 (QQQ), +0.14 with Bitcoin (BTC) and +0.06 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
1/3Most analysts rate it a buy ›
14 of 35 analysts rate it a buy or strong buy, 19 a hold and 2 a sell.Median target above the price ›
The median 12-month target of $111.00 is 13.8% above the price.More buy ratings than three months ago ›
14 of 35 rate it a buy now, against 16 of 36 three months ago.
SBUX Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 9, 2026 | DA Davidson | Maintains | Neutral |
| Oct 8, 2026 | UBS | Maintains | Neutral |
| Sep 29, 2026 | JP Morgan | Maintains | Overweight |
| Sep 16, 2026 | Seaport Global | Initiates | Neutral |
| Jul 31, 2026 | BTIG | Reiterates | Buy |
| Jul 30, 2026 | UBS | Maintains | Neutral |
As of October 16, 2026, 35 Wall Street analysts cover SBUX: 14 rate it a buy or strong buy, 19 a hold and 2 a sell or strong sell. Their 12-month price targets range from $82.00 to $143.00, with a median of $111.00, 13.8% above the price of $97.52.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
SBUX trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from SBUX's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much SBUX tends to move, against the market and on its own.
The long record
SBUX's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 1.46% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 42.2%, from July 2021 to May 2022; the price is still 12.5% below that peak.Most 1-year holds ended higher ›
64% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $22,791, against $42,525 in the S&P 500 (SPY).
SBUX Drawdowns & Recovery
As of October 16, 2026, SBUX's worst peak-to-trough fall over the last 10 years with dividends reinvested was -42.2% (July 2021 to May 2022); it is still 12.5% below that peak, and 64% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into SBUX in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: SBUX trailed the S&P 500 over this period: $22,791 against $42,525.
A $10,000 investment in SBUX in October 2016 would be worth about $22,791 today with dividends reinvested, compared with about $42,525 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to SBUX, and which have not.
Strongest month, November: an average of +6.99%, up in 9 of 10 years.
Weakest month, March: an average of -3.54%, up in 4 of 10 years.
This month, October: has averaged +0.84%, up in 8 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, SBUX's strongest calendar month has been November (average +6.99%, up in 9 of 10 years) and its weakest March (average -3.54%, up in 4 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in SBUX, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in SBUX today could grow to about $18,386 by 2036 in the base case, with a 90th-percentile outcome near $60,855 and a 10th-percentile outcome around $5,555. The simulation models price only; at today's 2.55% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
SBUX Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $124 for SBUX by 2030 in the base case, from $97.52 today (1.3x over 4 years). The 10th-percentile path ends near $58.36. These are outcomes of a Monte Carlo simulation run on SBUX's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $70.98 | $104 | $151 | |
| 2028 | $64.50 | $110 | $188 | |
| 2029 | $60.78 | $117 | $226 | |
| 2030 | $58.36 | $124 | $265 | |
| 2031 | $56.73 | $132 | $308 |
Method: a lognormal simulation of SBUX's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
SBUX insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $995K on the open market and sold $2.2M.
As of October 16, 2026, SBUX insiders reported 13 open-market sales worth $2.2M and 1 open-market purchase worth $995K over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 5, 2026 | Brady Brewer
Officer
|
Sell | 1.6K | $155.5K |
| Sep 4, 2026 | Brady Brewer
Officer
|
Sell | 2.2K | $235.4K |
| Aug 5, 2026 | Brady Brewer
Officer
|
Sell | 2.2K | $236.3K |
| Jul 6, 2026 | Brady Brewer
Officer
|
Sell | 2.2K | $231.8K |
| Jun 11, 2026 | Brady Brewer
Officer
|
Sell | 588 | $58.8K |
| Jun 5, 2026 | Brady Brewer
Officer
|
Sell | 1.6K | $154.8K |
| May 5, 2026 | Brady Brewer
Officer
|
Sell | 2.2K | $233.6K |
| Apr 29, 2026 | Sara Kelly
Officer
|
Sell | 2.0K | $210.0K |
| Apr 17, 2026 | Brady Brewer
Officer
|
Sell | 588 | $58.8K |
| Apr 6, 2026 | Brady Brewer
Officer
|
Sell | 1.6K | $147.7K |
| Mar 25, 2026 | Richard E Allison Jr
Director
|
Grant | 4.0K | - |
| Mar 25, 2026 | Andrew Campion
Director
|
Grant | 4.1K | - |
| Mar 25, 2026 | Beth E Ford
Director
|
Grant | 3.9K | - |
| Mar 25, 2026 | Jorgen Vig Knudstorp
Director
|
Grant | 4.7K | - |
| Mar 25, 2026 | Marissa A Mayer
Director
|
Grant | 3.7K | - |
| Mar 25, 2026 | Neal Mohan
Director
|
Grant | 3.7K | - |
| Mar 25, 2026 | Dambisa F Moyo
Director
|
Grant | 2.3K | - |
| Mar 25, 2026 | Daniel Servitje
Director
|
Grant | 3.7K | - |
| Mar 25, 2026 | G Michael Sievert
Director
|
Grant | 3.7K | - |
| Mar 25, 2026 | Wei Zhang
Director
|
Grant | 3.7K | - |
| Mar 9, 2026 | Brady Brewer
Officer
|
Sell | 588 | $58.8K |
| Mar 5, 2026 | Sara Kelly
Officer
|
Sell | 2.5K | $242.8K |
| Mar 5, 2026 | Brady Brewer
Officer
|
Sell | 1.6K | $159.4K |
| Nov 11, 2025 | Brady Brewer
Officer
|
Grant | 24.2K | - |
| Nov 11, 2025 | Michael David Grams
Chief Operating Officer
|
Grant | 18.5K | - |
| Nov 11, 2025 | Sara Kelly
Officer
|
Grant | 18.9K | - |
| Nov 11, 2025 | Bradley E Lerman
Officer
|
Grant | 5.4K | - |
| Nov 11, 2025 | Brian R Niccol
Chief Executive Officer
|
Grant | 106.5K | - |
| Nov 11, 2025 | Pilar Ramos
Officer
|
Grant | 16.2K | - |
| Nov 11, 2025 | Cathy R Smith
Chief Financial Officer
|
Grant | 20.8K | - |
| Nov 10, 2025 | Jorgen Vig Knudstorp
Director
|
Buy | 11.7K | $994.5K |
| Jul 1, 2025 | Marissa A Mayer
Director
|
Grant | 2.3K | - |
| Jul 1, 2025 | Dambisa F Moyo
Director
|
Grant | 1.4K | - |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 16, 2026.